Baillie Gifford - CUREVAC N V ownership

CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 91 filers reported holding CUREVAC N V in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of CUREVAC N V
ValueSharesWeighting
Q2 2022$3,909,000
-94.9%
287,249
-92.7%
0.00%
-92.6%
Q1 2022$76,702,000
-43.0%
3,911,347
-0.3%
0.05%
-27.0%
Q4 2021$134,610,000
-37.5%
3,923,340
-0.4%
0.07%
-34.5%
Q3 2021$215,243,000
-46.9%
3,940,731
-28.5%
0.11%
-42.6%
Q2 2021$405,261,000
-24.0%
5,515,262
-5.4%
0.20%
-33.9%
Q1 2021$533,221,000
+37.0%
5,830,101
+21.4%
0.30%
+37.3%
Q4 2020$389,271,000
+114.6%
4,801,656
+23.2%
0.22%
+73.6%
Q3 2020$181,381,0003,896,4750.12%
Other shareholders
CUREVAC N V shareholders Q2 2022
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,709,781$13,500,00010.67%
FOX RUN MANAGEMENT, L.L.C. 31,522$248,0000.10%
Green Alpha Advisors, LLC 12,598$99,0000.08%
Quantamental Technologies LLC 10,846$85,0000.03%
OCCUDO QUANTITATIVE STRATEGIES LP 49,034$386,0000.03%
Virtus ETF Advisers LLC 7,733$61,0000.02%
XTX Topco Ltd 12,040$95,0000.02%
ETF MANAGERS GROUP, LLC 55,320$436,0000.01%
TWINBEECH CAPITAL LP 46,360$365,0000.01%
Man Group plc 281,996$2,222,0000.01%
View complete list of CUREVAC N V shareholders